Back to Agenda
Session 2: Status in the EU and Use Cases
Session Chair(s)
Maren von Fritschen, PharmD
Head EU Regulatory Policy
Moderna, Netherlands
The benefits of patients’ registries and disease registries are increasingly recognized and various initiatives for data gathering are established by multiple stakeholders. The European Union plays a key role in facilitating the development of registries across borders within Europe by the PARENT JA and the European Medicines Agency Registry initiative whereas a variety of national registries are established and maintained. What is the current status in the EU and what can we learn from use cases?
Speaker(s)
Expectations and achievements of Registries from industry perspective
Chris Chinn, MSc
Sanofi, United Kingdom
Real World Evidence for Market Access
A Registry supporting continuous improve of treatment: case study of a breast cancer registry
Bent Ejlertsen
Danish Breast Cancer Cooperative Group Statistical Center, Denmark
Medical Director
Bo Terning Hansen
Cancer Registry of Norway, Norway
Researcher
Have an account?